A series of carbapenems containing novel C-2 semisaturated heterocyclic substituents were synthesised by 1,3 dipolar cycloaddition reactions of nitrile oxides, nitrile imines and a nitrone to 2-vinylcarbapenem. The isoxazoline and isoxazolidine compounds showed potent antibacterial activity but moderate stability to human dehydropeptidase 1 (DHP-1). Stability to DHP-1was improved by methyl substitution in the isoxazoline ring, but at the expense of antibacterial activity. The pyrazolines exhibited excellent stability to DHP-1, but reduced potency against Gram-negative organisms.
In the preceding paper1}, we described the synthesis, antibacterial activity and stability to human DHP-1 of a novel series of carbapenems containing non-aromatic heterocyclic substituents at the C-2 position. This report describes the use of 1,3 dipolar cycloaddition chemistry to synthesise new carbapenems with saturated and semisaturated heterocyclic substituents at C-2 and their biological properties.
Chemistry
Although several synthetic routes to carbapenems have been reported, we wanted to develop a methodology that would allow the facile synthesis of several C-2 heterocyclic analogues from a commonlate stage intermediate. To this end we investigated the possibility of using cycloaddition chemistry to construct heterocyclic systems by reaction of 1,3 dipoles with carbapenem dipolarophiles.
1,3 Dipolar cycloaddition to jS-lactam dipolarophiles was demonstrated in studies on nitrone2) and nitrile oxide3) cycloaddition to 3-vinyl cephems producing 3-(isoxazolidin-5-yl) and 3-(isoxazolin-5-yl)cephalosporins.
Indeed, a pro-drug of one of the resulting 3-(isoxazolidin-5-yl)cephalosporin showed promise as an orally active therapeutic agent4). Cycloaddition reactions have also been carried using cephem attached nitrile oxide5), nitrile imine and azide6) DEC. 1996 1,3 dipolarophiles. Very recently nitrone cycloaddition to 2-vinyl carbapenem as dipolarophile has been used to generate carbapenems with an isoxazolidine ring at C-2, which showed potent broad spectrum antibacterial activity7). 2-Vinyl carbapenem (2) was synthesised as reported8) by treatment of ketone 1 with triflic anhydride followed by Stille coupling of the resulting triflate with trimethylvinylstannane (Scheme 1).
Reaction of 2 with benzonitrile oxide, generated in situ by treatment of chlorobenzaldoxime with triethylamine, at room temperature afforded C-2 carbapenem isoxazoline with complete regioselectivity as a mixture of 2 diastereomers. The diastereomers, which were separated by silica gel chromatography, were obtained in approximately 1 : 1 ratio. The stereochemistry at C-5' could not be determined by NMR,nor could a crystalline compound be obtained of sufficient quality for X-ray structure determination. Previous work on the 3-(isoxazolin-5-yl)cephalosporins, for which the structure of a A2 isomer was determined by X-ray crystallography, established that the less polar isomers and more polar isomers have S and R configurations at C-5' respectively.
By analogy, we assumed that the same relationship between polarity and C-5' configuration applied to the structurally similar 2-(isoxazolin-5-yl)carbapenems and have tentatively assigned the stereochemistry accordPresent address: University of Southampton, Highfleld, Southampton, SO17 1BJ, U.K.
Scheme. 1. Synthesis of isoxazolines.
Scheme 2. Synthesis of pyrazolines.
Scheme 4. Synthesis of 4-and 5-methylisoxazolines.
Scheme 3. Synthesis of isoxazolidine.
ingly, although proof of this would require crystallographic structure determination. Hydrogenolysis of the 4-nitrobenzyl group followed by HP20SS purification gave the two diastereomeric 2-isoxazolinyl carbapenem salts 3 and 4. A number of other 2-isoxazolinyl carbapenems were prepared in similar manner.
Reaction of 1 with nitrile imines to give pyrazoline derivatives was also examined (Scheme 2). Nitrile imines were generated in situ by dropwise addition of triethylamine to chlorohydrazones 5. Overnight reaction gave the 2-(pyrazolin-5-yl)carbapenems as a diastereomeric mixture which was separable by silica gel chromatography. The yields obtained were similar to those obtained by nitrile oxide cycloaddition, and the ratio of the less polar to the more polar isomer was approximately 2:1. The corresponding sodium salts 6 and 7 were obtained as before.
Nitrone cycloaddition to 2 was investigated using isoquinoline TV-oxide 8 (Scheme 3). Although 8 is one of the most reactive nitrones, as dipoles nitrones are inherently less reactive dipoles than nitrile oxides and nitrile imines and cycloaddition to 2 required 5 hours reflux in toluene giving the cycloadduct 9 as a mixture of inseparable diastereoisomers.
In this case the cycloadduct was formed muchless cleanly than with nitrile oxides and nitrile imines and this is presumably due to the more forcing cycloadditon conditions which may have caused degradation of the carbapenem nucleus. Deprotection of 9 as before gave a diastereomeric mixture of carbapenem 10.
Modelling studies indicated that some 4-and 5-isoxazoline ring substituents on the isoxazolin-5-yl carbapenems could occupy the same space as a lj §-methyl substituent, and thus may confer stability to DHP-1. In order to test this hypothesis, several 2(4-and 5-methyl isoxazolin-5-yl)carbapenems were synthesised by benzonitrile oxide cycloaddition to methyl substituted dipolarophiles (Scheme 4). The precursor dipolarophiles ll were synthesised in moderate yield from 1 by Stille reaction with the appropriate vinylstannane8).
Discussion
The in vitro antibacterial activity of the synthesised compoundsagainst selected Gram-negative and Grampositive bacteria, including pathogens commonin community acquired infections, and stabilities to DHP-1are shown in Table 1 and compared with those of imipenem and meropenem. In general all the compounds displayed potent antibacterial activities, particularly against Gram-positive organisms. In the monosubstituted isoxazoline series (3, 4) , the activity against Grampositive organisms was independent of the substituent, DEC. 1996 although potency against showed improved overall antibacterial potency over diastereomer 1 (12m). The isoxazolidine (10) had similar antibacterial potency to phenyl isoxazoline (3d, 4d).
The pyrazoline series displayed similar activities against Gram-positive organisms but reduced activity against Gram-negative organisms compared to the isoxazoline series. For all the pyrazolines activity against E. coli was very much reduced, but the reduction in H. influenzae potency appeared to be related to the size of the TV-substituent i.e. methyl (6k, 7k)>2,2,2-trifluoroethyl (61, 71)>phenyl (6j, 7j). In contrast to the isoxazoline series, the activity against Gram-positive organisms of diastereomer 1 (6) was generally slightly better than diastereomer 2 (7), and there was little difference between the diastereomers in activities against
Gram-negative organisms.
None of the monosubstituted isoxazolines possessed stability to DHPequivalent or superior to meropenem.
As with antibacterial activity the nature of the isoxazoline 3-substituent appeared to have little effect on stability to DHP-1. However, there did appear to be a significant difference in stability to DHP-1 between the diastereomers with diastereomer 1 having greater stability than diastereomer 2. Interestingly, (S) diastereomers have been found to possess greater stability to DHP-1 than (R) diastereomers for C-2 tetrahydrofuran-2-yl and tetrahydrothiophen-2-yl carbapenems1}, and this is consistent with the tentative assignment of (S)-stereochemistry to diastereomer 1 of the isoxazoline series. Methyl substitution at position 4 of the isoxazoline appeared to have little effect on the stability of diastereomer 1 (12m and 12n vs. 3d) although a significant improvement was noted for diastereomer 2 (13m and 13n vs. 4d). Thus, 4-substitution reduced the difference in stability to DHP-1 between the diastereomers. However, orientation of the methyl group (cis or trans) to the ring junction did not significantly alter stability to DHP-1. The only isoxazoline compounds that did show better stability than meropenemwere the 5-methyl isoxazolines 12o and 13o, with similar stability to DHP-1 demonstrated for both diastereomers. The isoxazolidine 10 showed poorer stability than meropenem, however the 1 ,3 disubstituted pyrazoline series did exhibit stability to DHP-1 equivalent or superior to meropenem and as with the isoxazolines, diastereomer 1 (6) was more stable than diastereomer 2 (7).
In summary it has been shown that 1,3 dipolar cycloaddition chemistry can be used to prepare a numberof C-2 semisaturated heterocyclic carbapenems which have potent broad spectrum antibacterial activities. C-2 carbapenem isoxazolines showed the most potent antibacterial activities but their stabilities to DHP-1 were poorer than meropenem. Attempts to improve stability by introduction of substituents at C-5 did produce stable 1269 compoundsbut at the expense of reduced activity against
Gram-negative organisms. The pyrazoline series also showed good stability to DHP-1 but had less Gramnegative potency than the monosubstituted isoxazolines. The reduction in Gram-negative activity appeared to be related to the steric demandsof the substituents on the C-2 heterocycle which were not directly responsible for stability to DHP-1.
Experimental
XHNMRspectra were recorded on a Bruker AC250 spectrometer. IR spectra were measured in solution or After 0.5 hour a further 1 Eq of aminocarbonyl nitrile oxide generated in situ as above was added and the mixture was stirred for 1 hour. The reaction mixture was evaporated to dryness and ethyl acetate (100ml) was added and the mixture was washed with water (50ml). The aqueous phase was extracted with ethyl acetate (100ml) and the combined organic extracts were dried and evaporated under reduced pressure. The residue was chromatographed (silica gel, 1 :2~1 :4 hexane-ethyl acetate and 100% ethyl acetate eluent) and gave p- General Procedure for Hydrogenolysis 1996 stereomer A (60mg, 0.12mmol) and palladium catalyst (3% on carbon, 10mg) in THF (2ml) and phosphate buffer (0.2m, pH 7, l ml) was hydrogenated (1 atm) at roomtemperature for 5 minutes, and the catalyst was removed by filtration through a celite pad and washed with water (50 ml). Sodium bicarbonate (4 mg, 48 /miol) was added and the mixture was evaporated to remove THF, and then extracted with ethyl acetate (50 ml). The aqueous phase was concentrated in vacuo to ca. Hamilton AT + liquid handling technology, and defined as the minimuminhibitory concentration (MICin jUg/ml) needed to inhibit growth of the micro-organism. MuellerHinton Broth (Difco) was used as the growth medium;
for growth of the more fastidious micro-organisms (S. pneumoniae, H. influenzae and M. catarrhalis) this was supplemented with sterile heat-inactivated donor horse serum (ICN Biomedicals) -5%; hematin (Sigma) -0.02 mg/ml and NAD(-nicotinamide adenine dinucleotide, Sigma)-0.08mg/ml (all final concentrations). Overnight broth cultures were added to give a final concentration of 5 x 105 cfu/ml. Plates were incubated at 37°C for 18 hours.
Determination of Stability to DHP-1 (i) HPLC Method The test compound (0.5 mmol solution in 0.02 m MOPS at pH 7.0) (0.08ml) was challenged with pure DHP-1 enzyme (0.08 ml of 2.5 //g/ml solution) at 37°C. Samples were removed at 0, 30, 60, and 90 minute time points and analysed by reverse phase HPLC. The hydrolysis of the carbapenemwas monitored by integration of the area under the peak for the test compound.The results were submitted to a statistical evaluation programmewhich allowed for the calculation of the percentage of test compoundremaining intact after 60 minutes. Control experiments were conducted for each test compoundto check its stability in buffer alone. Table 3 . Spectral data for compounds 6 and 7j~l and 10. (ii) Spectrophotometric Method
The test compounds were challenged with the pure DHP-1enzyme as described above. Rates of hydrolysis were recorded on a UVspectrophotometer at time points between 0 and 90 minutes. Absorbance changes were converted to concentration changes by prior analysis of wavelength scans for each test compound(concentration as above) in the presence of Bacillus cereus metallo-/?-lactamase (100ng).
Assumptions made are that each compoundis completely hydrolysed by the /Mactamase, that the absorbance changes caused by each enzyme are the same, and that the rate of change of the hydrolysis by metallo-/?-lactamase is linear. The standard compound, meropenem, is assayed in each screen and the results quoted as hydrolysis rates relative to meropenem. Control experiments were conducted for each test compound to check its stability in buffer alone.
